Genmab reported DKK3.27B in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
Almirall ALM:SM EUR 13.9M 14.3M
Amarin AMRN:US USD -3883000 60.92M
Argen X Bv ARGX:BB USD -241024000 24.05M
AstraZeneca AZN:LN USD 3.09B 52M
Bluebird Bio BLUE:US USD -76513000 16.99M
Exelixis EXEL:US USD 92.04M 3.53M
Fresenius Medical Care FME:GR EUR 397M 50M
Genmab GEN:DC DKK 3.27B 783M
GlaxoSmithKline GSK:LN GBP 2.43B 602M
GN Store Nord GN:DC DKK 273M 52M
Hikma Pharmaceutical HIK:LN USD 251M 28M
Immunogen IMGN:US USD -77755000 15.73M
Insmed INSM:US USD -130773000 35.63M
Merck MRK:GR EUR 1.29B 108M
Novartis NOVN:VX USD 4.06B 72M
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
William Demant Holding WDH:DC DKK 1.49B 214M